Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Other Operating Expenses (2016 - 2019)

Northwest Biotherapeutics (NWBO) has 10 years of Other Operating Expenses data on record, last reported at -$100000.0 in Q4 2020.

  • For Q4 2020, Other Operating Expenses rose 96.93% year-over-year to -$100000.0; the TTM value through Sep 2021 reached -$100000.0, up 96.83%, while the annual FY2018 figure was $4.5 million, 50.18% down from the prior year.
  • Other Operating Expenses reached -$100000.0 in Q4 2020 per NWBO's latest filing, down from $100000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $3.9 million in Q1 2017 and bottomed at -$3.3 million in Q4 2019.
  • Average Other Operating Expenses over 5 years is $1.0 million, with a median of $1.1 million recorded in 2016.
  • Peak YoY movement for Other Operating Expenses: soared 31433.33% in 2016, then plummeted 826.56% in 2019.
  • A 5-year view of Other Operating Expenses shows it stood at $1.5 million in 2016, then dropped by 2.33% to $1.5 million in 2017, then plummeted by 70.35% to $448000.0 in 2018, then tumbled by 826.56% to -$3.3 million in 2019, then soared by 96.93% to -$100000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were -$100000.0 in Q4 2020, $100000.0 in Q2 2020, and -$3.3 million in Q4 2019.